jameshebrew  created a new article
11 w

The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis | #fc fusion therapies # Fc fusion therapeutics # RootsAnalysis

The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis

The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis

Since the approval of Enbrel® in 1998 for the treatment of rheumatoid arthritis, Fc fusion therapies have evolved into a prominent class of therapeutics; currently, several therapies are being developed for a variety of disease indications